Industry: Chemical & Material
Published Date: 2025-07-17
Pages: 93 Pages
Report ld: 4348790
Request Sample
Customized Report
Prasterone Market Size(US$)

CAGR 2025-2031
7.2%
Market Size,2031
USD 75.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Prasterone was valued at US$ 49.3 million in the year 2024 and is projected to reach a revised size of US$ 75.9 million by 2031, growing at a CAGR of 7.2% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prasterone competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Prasterone, the synthetic equivalent of endogenous dehydroepiandrosterone (DHEA), has emerged as a key player in the field of hormone-based therapies. Traditionally recognized for its role in alleviating menopausal symptoms—particularly moderate to severe dyspareunia—it is increasingly being investigated for broader applications including anti-aging, cognitive enhancement, and even immune modulation. With its ability to convert locally into estrogens and androgens, prasterone represents a unique therapeutic modality with minimal systemic exposure, garnering interest from both the medical and wellness communities.
Research institutions and pharmaceutical companies are increasingly exploring prasterone’s potential in areas beyond its current indications, including neuroprotection and metabolic modulation. This diversification is expected to broaden the market scope over the next several years.
In developed markets like the United States and Europe, prasterone is gaining traction as part of a broader trend toward hormone replacement therapies. The aging population’s growing need for treatments that address not only physical but also sexual and cognitive declines is fuelling this demand.
With DHEA levels naturally declining after age 30—more rapidly in women—the need for interventions that restore hormonal balance is becoming more pronounced. This demographic shift is a primary market driver for prasterone-based therapies.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Prasterone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prasterone.
The Prasterone market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prasterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prasterone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Yicheng Goto Pharmaceuticals Co.,Ltd.
Junye Pharmaceutical Co., Ltd.
Zhejiang Shenzhou Pharmaceutical Co., Ltd.
Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
Jiangsu Jiaerke Pharmaceuticals Group Corp.
Hubei Dan’ao Pharmaceutical Co., Ltd.
Wudang Antai Pharmaceutical Co., Ltd.
Shandong Saito Biotechnology Co., Ltd.
NutriScience Innovations, LLC
Segment by Type
≥98%
Others
Segment by Application
Medicine
Dietary Supplements
Skin Care Products
Reagents
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prasterone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Prasterone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Prasterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Prasterone Market Overview
1.1 Product Definition
1.2 Prasterone by Type
1.2.1 Global Prasterone Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 ≥98%
1.2.3 Others
1.3 Prasterone by Application
1.3.1 Global Prasterone Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medicine
1.3.3 Dietary Supplements
1.3.4 Skin Care Products
1.3.5 Reagents
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Prasterone Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Prasterone Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Prasterone Production Estimates and Forecasts (2020-2031)
1.4.4 Global Prasterone Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Prasterone Production Market Share by Manufacturers (2020-2025)
2.2 Global Prasterone Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Prasterone, Industry Ranking, 2023 VS 2024
2.4 Global Prasterone Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Prasterone Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Prasterone, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Prasterone, Product Offered and Application
2.8 Global Key Manufacturers of Prasterone, Date of Enter into This Industry
2.9 Prasterone Market Competitive Situation and Trends
2.9.1 Prasterone Market Concentration Rate
2.9.2 Global 5 and 10 Largest Prasterone Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Prasterone Production by Region
3.1 Global Prasterone Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Prasterone Production Value by Region (2020-2031)
3.2.1 Global Prasterone Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Prasterone by Region (2026-2031)
3.3 Global Prasterone Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Prasterone Production Volume by Region (2020-2031)
3.4.1 Global Prasterone Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Prasterone by Region (2026-2031)
3.5 Global Prasterone Market Price Analysis by Region (2020-2025)
3.6 Global Prasterone Production and Value, Year-over-Year Growth
3.6.1 North America Prasterone Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Prasterone Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Prasterone Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Prasterone Production Value Estimates and Forecasts (2020-2031)
4 Prasterone Consumption by Region
4.1 Global Prasterone Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Prasterone Consumption by Region (2020-2031)
4.2.1 Global Prasterone Consumption by Region (2020-2025)
4.2.2 Global Prasterone Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Prasterone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Prasterone Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Prasterone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Prasterone Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Prasterone Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Prasterone Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Prasterone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Prasterone Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Prasterone Production by Type (2020-2031)
5.1.1 Global Prasterone Production by Type (2020-2025)
5.1.2 Global Prasterone Production by Type (2026-2031)
5.1.3 Global Prasterone Production Market Share by Type (2020-2031)
5.2 Global Prasterone Production Value by Type (2020-2031)
5.2.1 Global Prasterone Production Value by Type (2020-2025)
5.2.2 Global Prasterone Production Value by Type (2026-2031)
5.2.3 Global Prasterone Production Value Market Share by Type (2020-2031)
5.3 Global Prasterone Price by Type (2020-2031)
6 Segment by Application
6.1 Global Prasterone Production by Application (2020-2031)
6.1.1 Global Prasterone Production by Application (2020-2025)
6.1.2 Global Prasterone Production by Application (2026-2031)
6.1.3 Global Prasterone Production Market Share by Application (2020-2031)
6.2 Global Prasterone Production Value by Application (2020-2031)
6.2.1 Global Prasterone Production Value by Application (2020-2025)
6.2.2 Global Prasterone Production Value by Application (2026-2031)
6.2.3 Global Prasterone Production Value Market Share by Application (2020-2031)
6.3 Global Prasterone Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone Company Information
7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone Product Portfolio
7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Main Business and Markets Served
7.1.5 Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Developments/Updates
7.2 Junye Pharmaceutical Co., Ltd.
7.2.1 Junye Pharmaceutical Co., Ltd. Prasterone Company Information
7.2.2 Junye Pharmaceutical Co., Ltd. Prasterone Product Portfolio
7.2.3 Junye Pharmaceutical Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Junye Pharmaceutical Co., Ltd. Main Business and Markets Served
7.2.5 Junye Pharmaceutical Co., Ltd. Recent Developments/Updates
7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
7.3.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone Company Information
7.3.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone Product Portfolio
7.3.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Main Business and Markets Served
7.3.5 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Developments/Updates
7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone Company Information
7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone Product Portfolio
7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Main Business and Markets Served
7.4.5 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5 Jiangsu Jiaerke Pharmaceuticals Group Corp.
7.5.1 Jiangsu Jiaerke Pharmaceuticals Group Corp. Prasterone Company Information
7.5.2 Jiangsu Jiaerke Pharmaceuticals Group Corp. Prasterone Product Portfolio
7.5.3 Jiangsu Jiaerke Pharmaceuticals Group Corp. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jiangsu Jiaerke Pharmaceuticals Group Corp. Main Business and Markets Served
7.5.5 Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Developments/Updates
7.6 Hubei Dan’ao Pharmaceutical Co., Ltd.
7.6.1 Hubei Dan’ao Pharmaceutical Co., Ltd. Prasterone Company Information
7.6.2 Hubei Dan’ao Pharmaceutical Co., Ltd. Prasterone Product Portfolio
7.6.3 Hubei Dan’ao Pharmaceutical Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Hubei Dan’ao Pharmaceutical Co., Ltd. Main Business and Markets Served
7.6.5 Hubei Dan’ao Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7 Wudang Antai Pharmaceutical Co., Ltd.
7.7.1 Wudang Antai Pharmaceutical Co., Ltd. Prasterone Company Information
7.7.2 Wudang Antai Pharmaceutical Co., Ltd. Prasterone Product Portfolio
7.7.3 Wudang Antai Pharmaceutical Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Wudang Antai Pharmaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Wudang Antai Pharmaceutical Co., Ltd. Recent Developments/Updates
7.8 Shandong Saito Biotechnology Co., Ltd.
7.8.1 Shandong Saito Biotechnology Co., Ltd. Prasterone Company Information
7.8.2 Shandong Saito Biotechnology Co., Ltd. Prasterone Product Portfolio
7.8.3 Shandong Saito Biotechnology Co., Ltd. Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Shandong Saito Biotechnology Co., Ltd. Main Business and Markets Served
7.8.5 Shandong Saito Biotechnology Co., Ltd. Recent Developments/Updates
7.9 NutriScience Innovations, LLC
7.9.1 NutriScience Innovations, LLC Prasterone Company Information
7.9.2 NutriScience Innovations, LLC Prasterone Product Portfolio
7.9.3 NutriScience Innovations, LLC Prasterone Production, Value, Price and Gross Margin (2020-2025)
7.9.4 NutriScience Innovations, LLC Main Business and Markets Served
7.9.5 NutriScience Innovations, LLC Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Prasterone Industry Chain Analysis
8.2 Prasterone Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Prasterone Production Mode & Process Analysis
8.4 Prasterone Sales and Marketing
8.4.1 Prasterone Sales Channels
8.4.2 Prasterone Distributors
8.5 Prasterone Customer Analysis
9 Prasterone Market Dynamics
9.1 Prasterone Industry Trends
9.2 Prasterone Market Drivers
9.3 Prasterone Market Challenges
9.4 Prasterone Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Prasterone market size was US$ 50.11 million in 2025 and is forecast to reach a readjusted size of US$ 80.82 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
The global market for Prasterone was estimated to be worth US$ 50.11 million in 2025 and is projected to reach US$ 80.82 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 100
USD 3950.00
(Single User License)
The global Prasterone market was valued at US$ 50.11 million in 2025 and is anticipated to reach US$ 80.82 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 134
USD 2900.00
(Single User License)
The global Prasterone market is projected to grow from US$ 49.3 million in 2024 to US$ 75.9 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-17
Pages: 147
USD 4900.00
(Single User License)
The global market for Prasterone was estimated to be worth US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-07-17
Pages: 109
USD 3950.00
(Single User License)
The global Prasterone market size was US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-07-17
Pages: 77
USD 4250.00
(Single User License)
Valued at US$ 80.8 million in 2024, the global Prasterone market is forecast to reach US$ 110 million by 2030, at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-28
Pages: 115
USD 4900.00
(Single User License)
The global Prasterone market size was US$ 50.11 million in 2025 and is forecast to reach a readjusted size of US$ 80.82 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
The global market for Prasterone was estimated to be worth US$ 50.11 million in 2025 and is projected to reach US$ 80.82 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-05
Pages: 100
The global Prasterone market was valued at US$ 50.11 million in 2025 and is anticipated to reach US$ 80.82 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-05
Pages: 134
The global Prasterone market is projected to grow from US$ 49.3 million in 2024 to US$ 75.9 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-17
Pages: 147
The global market for Prasterone was estimated to be worth US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-07-17
Pages: 109
The global Prasterone market size was US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-07-17
Pages: 77
Valued at US$ 80.8 million in 2024, the global Prasterone market is forecast to reach US$ 110 million by 2030, at a CAGR of 5.3% during the forecast period.
Published: 2025-02-28
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now